Adherex Technologies, Inc.
31Patents
2Active
31Granted
32Portfolio score
Filing activity: Dec 31, 1997 → Oct 14, 2010 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6682901B2 | Methods for diagnosing and evaluating cancer | Emerging Cross-Sectional Technologies | 33 | Expired |
| US6358920B1 | Compounds and methods for modulating nonclassical cadherin-mediated functions | Emerging Cross-Sectional Technologies | 32 | Expired |
| US7446120B2 | Peptidomimetic modulators of cell adhesion | Chemistry; Metallurgy | 30 | Active |
| US6391855B1 | Compounds and methods for modulating junctional adhesion molecule-mediated functions | Human Necessities | 20 | Expired |
| US6303576A | Compounds and methods for modulating .beta.-catenin mediated gene expression | Chemistry; Metallurgy | 19 | Expired |
| US6433149B1 | Compounds and methods for inhibiting cancer metastasis | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6638911B1 | Compounds and methods for modulating desmosomal cadherin-mediated functions | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6277824A | Compounds and methods for modulating adhesion molecule function | Chemistry; Metallurgy | 14 | Expired |
| US6110747A | Compounds and methods for modulating tissue permeability | Human Necessities | 13 | Expired |
| US6569996B1 | Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6472367B1 | Compounds and methods for modulating OB-cadherin mediated cell adhesion | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6310177A | Compounds and methods for modulating tissue permeability | Human Necessities | 12 | Expired |
| US6472368B1 | Compounds and methods for modulating adhesion molecule function | Chemistry; Metallurgy | 10 | Expired |
| US6830894B1 | Compounds and methods for modulating claudin-mediated functions | Human Necessities | 9 | Expired |
| US6248864A | Compounds and methods and modulating tissue permeability | Human Necessities | 9 | Expired |
| US6962969B2 | Compounds and methods for modulating nonclassical cadherin-mediated functions | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7456153B2 | Compounds and methods for modulating functions of classical cadherins | Human Necessities | 7 | Expired |
| US6677116B1 | Methods for treating cancer by modulating &bgr;-catenin mediated gene expression | Chemistry; Metallurgy | 5 | Expired |
| US6680175B2 | Methods for diagnosing and evaluating cancer | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6806255B2 | Compounds and methods for modulating adhesion molecule function | Chemistry; Metallurgy | 4 | Expired |
| US7268115B2 | Peptidomimetic modulators of cell adhesion | Chemistry; Metallurgy | 4 | Expired |
| US6797807B1 | Compounds and methods for cancer therapy | Human Necessities | 4 | Expired |
| US6593297B2 | Compounds and methods for inhibiting cancer metastasis | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7476509B2 | Compounds and methods for modulating functions of nonclassical cadherins | Human Necessities | 2 | Expired |
| US6723700B1 | Compounds and methods for modulating claudin-mediated functions | Human Necessities | 2 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.